vivoChip - The next generation of microfluidic screening solutions

vivoChip enables rapid immobilization and high-resolution imaging of C. elegans

High-resolution imaging of entire germline organization

vivoChip-96x: The first large-scale screening platform for C. elegans

Newormics rental plans now available!

Webinar on demand

Purchase any pack of vivoChips and take advantage of our flexible and affordable vivoCube rental plans, to run the experiments you want now with no up-front equipment purchase

High-content analysis of disease models and toxicology studies using C. elegans

previous arrow
next arrow

our focus

Newormics offers advanced microfluidic devices for high-throughput and high-content screening of small animal models and 3D tissue organoids.

We also provide toxicology services and solutions.

See how vivoChip® enables rapid immobilization and alignment of multiple worms for high resolution imaging




We are a team of innovators from Austin in the fields of microfluidics, life-science imaging, and chemical screening.

Adela Ben-Yakar, PhD

Chief Executive Officer, Co-Founder
A professor with dual appointments in Mechanical Engineering and Biomedical Engineering at The University of Texas at Austin, Dr Ben Yakar’s research focuses on the creation of imaging technologies and novel laser surgery with high precision. Educated at Stanford and the Technion in Israel, with post-doctoral study at Harvard, and using her NIH Director’s Transformative Research Award, Dr Ben Yakar began the research that has culminated in the launch of Newormics, LLC.

Evan Hegarty

Dir. of Manufacturing, Co-Founder
Evan Hegarty, co-founder, received his M.S. in Mechanical Engineering at The University of Texas at Austin while developing the technology and IP that lead to the launch of Newormics, LLC. As the Director of Manufacturing and Product development, and Principal Investigator of NIH SBIR grants at Newormics, Evan is responsible for development of all chip and system designs, creating production schedules, optimizing production methods, managing team members, identifying customer needs, developing future products, and reinforcing GLP and GMP.

Adam Laing, PHD

Dr. Adam Laing is a molecular and cellular biologist educated at the University of Edinburgh, and leads the Research and Development activities of Newormics. He is responsible for testing and characterizing the new devices and imaging methods, and development of toxicology and drug screening assays in C. elegans as well as tissue organoids.

Gina Lento, PhD

Head of Operations
Dr. Lento is a serial COO/VPO executive for life science startups with broad skills in pharmaceuticals, medical devices, and diagnostics. With a unique background of equal parts government, public and private sector service, Dr. Lento holds a PhD in Biochemistry and additional credentials in Drug Evaluation, Pharmaceutical Sciences, and Corporate Governance.


More news...

Contact us about your needs and get a quote